Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series

por Bosma, A. L., Gerbens, L. A. A., Middelkamp‐Hup, M. A., Spuls, P. I.
Publicado 2021

Finalizing the international core domain set for peripheral vascular malformations: the OVAMA project

por Lokhorst, M.M., Horbach, S.E.R., van der Horst, C.M.A.M., Spuls, P.I.
Publicado 2019

Measurement instruments for the core outcome set of congenital melanocytic naevi and an assessment of the measurement properties according to COSMIN: a systematic review

por Fledderus, A.C., Boom, T., Legemate, C.M., van der Horst, C.M.A.M., Spuls, P.I.
Publicado 2022

The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: an online survey study amongst patients and physicians

por van der Kraaij, G.E., Vermeulen, F.M., Smeets, P.M.G., Smets, E.M.A., Spuls, P.I.
Publicado 2020

Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?

por Hurault, G., Roekevisch, E., Schram, M. E., Szegedi, K., Kezic, S., Middelkamp‐Hup, M. A., Spuls, P. I., Tanaka, R. J.
Publicado 2022

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐...

por Vermeulen, F.M., Gerbens, L.A.A., Schmitt, J., Deleuran, M., Irvine, A.D., Logan, K., Ouwerkerk, W., Vestergaard, C., Flohr, C., Spuls, P.I.
Publicado 2020

Development of a condition‐specific patient‐reported outcome measure for measuring symptoms and appearance in vascular malformations: the OVAMA questionnaire

por Lokhorst, M.M., Horbach, S.E.R., Young‐Afat, D.A., Stor, M.L.E., Haverman, L., Spuls, P.I., van der Horst, C.M.A.M.
Publicado 2021

Responsiveness of quality of life measures in children with peripheral vascular malformations: The OVAMA project

por Lokhorst, M.M., Horbach, S.E.R., Waner, M., O, T.M., van der Vleuten, C.J.M., Spuls, P.I., van der Horst, C.M.A.M.
Publicado 2020

Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research (the OCOMEN project): part 2

por Fledderus, A.C., Pasmans, S.G.M.A., Wolkerstorfer, A., Oei, W., Etchevers, H.C., van Kessel, M.S., van der Horst, C.M.A.M., Spuls, P.I.
Publicado 2021

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

por Drucker, A.M., Eyerich, K., de Bruin‐Weller, M.S., Thyssen, J.P., Spuls, P.I., Irvine, A.D., Girolomoni, G., Dhar, S., Flohr, C., Murrell, D.F., Paller, A.S., Guttman‐Yassky, E.
Publicado 2018

Responsiveness of quality‐of‐life measures in patients with peripheral vascular malformations: the OVAMA project

por Lokhorst, M.M., Horbach, S.E.R., Waner, M., O, T.M., van der Vleuten, C.J.M., Mokkink, L.B., van der Horst, C.M.A.M., Spuls, P.I.
Publicado 2019

Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics

por Bosma, A.L., Ascott, A., Iskandar, R., Farquhar, K., Matthewman, J., Langendam, M.W., Mulick, A., Abuabara, K., Williams, H.C., Spuls, P.I., Langan, S.M., Middelkamp‐Hup, M.A.
Publicado 2022

Do patient characteristics matter when calculating sample size for eczema clinical trials?

por Howells, L., Gran, S., Chalmers, J. R., Stuart, B., Santer, M., Bradshaw, L., Gaunt, D. M., Ridd, M. J., Gerbens, L. A. A., Spuls, P. I., Huang, C., Francis, N. A., Thomas, K. S.
Publicado 2021

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients

por Roekevisch, E., Szegedi, K., Hack, D.P., Schram, M.E., Res, P.C.J.M., Bos, J.D., Leeflang, M.M.G., Luiten, R.M., Kezic, S., Spuls, P.I., Middelkamp‐Hup, M.A.
Publicado 2020

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries

por Vermeulen, F.M., Gerbens, L.A.A., Bosma, A.L., Apfelbacher, C.J., Irvine, A.D., Arents, B.W.M., Barbarot, S., Deleuran, M., Eichenfield, L.F., Manca, A., Schmitt, J., Vestergaard, C., Wall, D., Weidinger, S., Middelkamp‐Hup, M.A., Spuls, P.I., Flohr, C.
Publicado 2019

TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and sys...

por Gerbens, L.A.A., Apfelbacher, C.J., Irvine, A.D., Barbarot, S., de Booij, R.J., Boyce, A.E., Deleuran, M., Eichenfield, L.F., Hof, M.H., Middelkamp‐Hup, M.A., Roberts, A., Schmitt, J., Vestergaard, C., Wall, D., Weidinger, S., Williamson, P.R., Flohr, C., Spuls, P.I.
Publicado 2018

Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting

por Thomas, K.S., Apfelbacher, C.A., Chalmers, J.R., Simpson, E., Spuls, P.I., Gerbens, L.A.A., Williams, H.C., Schmitt, J., Gabes, M., Howells, L., Stuart, B.L., Grinich, E., Pawlitschek, T., Burton, T., Howie, L., Gadkari, A., Eckert, L., Ebata, T., Boers, M., Saeki, H., Nakahara, T., Katoh, N.
Publicado 2021

Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project)

por Langbroek, G.B., Wolkerstorfer, A., Horbach, S.E.R., Spuls, P.I., Kelly, K.M., Robertson, S.J., van Raath, M.I., Al‐Niaimi, F., Kono, T., Boixeda, P., Laubach, H.J., Badawi, A.M., Troilius Rubin, A., Haedersdal, M., Manuskiatti, W., van der Horst, C.M.A.M., Ubbink, D.T.
Publicado 2021